P-selectin was shown t o bind committed human hematopoietic progenitors (colony-forming unit-granulocyte-macrophage [CFU-GM] and burst-forming unit-erythroid [BFU-El) as identified by their expression of the CD34 antigen and by in vitro clonogenic assays. In addition, P-selectin bound all precursors (pre-CFU) of committed myeloid progenitors assayed by their ability t o sustain hematopoiesis in both conventional stroma-containing and stroma-free, cytokine-dependent systems. Binding of CD34' cells t o P-selectin was temperature-independent and shear-resistant, occurred only in the presence of divalent cations, was protease sensitive, and was completely blocked by anti-P-selectin antibody. Neuraminidase treatment of CD34+ cells completely abrogated their binding t o P-selectin, implying a prominent role for sialic acid in the structure and function of the P-selectin ligand on hematopoietic progenitors. Monoclonal antibodies (MoAbs) CSLEX-1 and HECA-452, which identify carbohydrate epitopes involving sialic acid, bound t o 33% and 35%
EMATOPOIESIS occurs normally in the bone marrow (BM), where the precursors and progeny of multiple myeloid and lymphoid lineages develop in intimate association with cells that comprise the BM microenvironment.'-8 Cellular interactions between immature hematopoietic progenitor cells and the stroma are of major importance in the regulation of hematopoiesis and in all likelihood serve multiple functions ranging from the retention of primitive hematopoietic stem cells within the BM to the regulation of the release of mature hematopoietic cells into the circulati~n.'."'"~ In addition, such interactions may be responsible for the homing of hematopoietic stem cells to the marrow after either BM transplantation or endogenous migrationi2 or to homing to extramedullary sites in disease states that involve new sites of hematopoiesis.
The interactions that occur between primitive hematopoi-of CD34+ cells, respectively, and included the majority of CFU-GM and pre-CFU. Three-color flow cytometric analysis showed a precise codistribution of CSLEX-1 and HECA-452 antigens on CD34' cells, implying recognition of the same glycoprotein antigen by the two MoAbs. Treatment of CD34+ cells with neuraminidase completely abolished binding of both MoAbs. In addition, HECA-452 partially blocked the adhesion of CD34' cells t o P-selectin. P-selectin glycoprotein ligand (PSGL-11, recently molecularly cloned from the promyelocytic leukemia cell line HL60, was expressed by 0 3 4 ' cells as determined by reverse transcription polymerase chain reaction. Combined with the functional and biochemical characteristics, these data suggest that PSGL-1 may comprise an important P-selectin ligand expressed by primitive hematopoietic cells, but do not preclude the existence of additional P-selectin ligands on these cells. Q 1995 b y The American Society of Hematology.
etic progenitors and marrow stromal elements are many and varied, involving both cell-cell and cell-extracellular matrix (ECM) a d h e~i o n . '~~~"~~' The cell adhesion molecules (CAMs) that mediate these interactions may function in a stage-and/ or lineage-specific manner as occurs, eg, in T-cell development.'6.i7 Current data support the hypothesis that a variety of CAMs are involved in mediating a range of interactions throughout hernat~poiesis.'~"~ However, despite intensive research, the molecular mechanisms responsible for the homing of stem cells to the BM are poorly understood.'* In mammals, hematopoiesis is restricted to the extravascular compartment of the BM that is separated from the vascular compartment by a single layer of endothelial cells that form specialized vessels termed sinusoid^.^.' Thus, to enter the hematopoietic compartment, stem cells arriving at the marrow must first recognize or be recognized by the luminal surface of the endothelium. Molecules that mediate adhesion of hematopoietic stem cells to vascular endothelial cells are therefore likely to play a pivotal role in the phenomenon of stem cell homing, but, thus far, such molecules have yet to be identified. The selectins are a family of three structurally related integral membrane glycoproteins that regulate leukocyte adhesion to platelets and/or endothelium during inflammation by means of selective protein-carbohydrate interactions mediated by the lectin-like domain at the N-terminus of each family member.'"'' Leukocyte (L)-selectin (CD62L) is constitutively expressed by neutrophils, monocytes, and lymphocytes,2i.Z4 whereas endothelial cell (E)-and platelet (P)-selectins (CD62E and CD62P, respectively) are expressed on activated endothelial cell^.'^^^^' P-selectin (PADGEM protein, GMP-140, and CD62P) is a 140-kD transmembrane protein expressed by vascular endothelial cells and platelets.'".z'.'6 The protein is stored preformed in the Weibel-Palade bodies of endothelial cells" and in the a granules of platelets." Upon stimulation of these cells with a variety of agonists such as thrombin, histamine, and calcium ionophore A231 87, P-selectin is rapidly (within minutes) translocated to the cell ~u r f a c e ,~~~* ' where it mediates leukocyte-platelet'" and leukocyte-vascular endo- For personal use only. on October 23, 2017. by guest www.bloodjournal.org From thelial cell adhesion.31s32 P-selectin binds to leukocytes by interacting with carbohydrate ligand(s) on opposing cells,21*22~31 although the precise composition of the physiologic ligand(s) of P-selectin remains to be determined. The interaction of P-selectin with mature leukocytes is in part responsible for mediating leukocyte rolling on the vascular cell ~a 1 1 , 3~,~~ an early event in leukocyte recruitment at sites of i n f l a m m a t i~n . '~.~~. ~~ We report here that, in addition to its role as a receptor for mature leukocytes (neutrophils and monocytes), P-selectin also functions as a cell adhesion molecule for leukocyte precursor cells in the BM, including both lineage-restricted clonogenic progenitors (colony-forming unit-granulocytemacrophage [Cm-GM] and burst-forming unit-erythroid [BFU-E]) and hierarchically more primitive progenitor cells (pre-CFU).
MATERIALS AND METHODS

BM Cells and Fluorescence-Activated Cell Sorting (FACS)
BM was aspirated from the posterior iliac crest in heparin from healthy young volunteers after informed consent was obtained. The use of normal BM cells for these studies was approved by the Human Ethics Committee of the Royal Adelaide Hospital. BM mononuclear cells (BMMNC) were collected after centrifugation at 400g over Ficoll (Lymphoprep, 1.077 g/dL; Nycomed Pharma AS, Oslo, Norway) and washed twice by centrifugation at 4°C in HHF (Hank's Balanced Salt Solution [HBSS; GIBCO/BRL, Glen Waverley, Victoria, Australia] supplemented with 20 mmoVL HEPES, pH 7.35, and 5% voVvol fetal calf serum [FCS; PA Biologicals, Sydney, NSW, Australia]). Before immunolabelling, BMMNC were incubated in HHF supplemented with 2% normal human serum (HHF-NHS) for 30 minutes on ice to block Fc receptors. Labeling with the anti-CD34 HPCA-2-PE (Becton Dickinson, Mountain View, CA) was performed as previously de~cribed.~' Cell sorting was performed using a FACStdLUS cell sorter (Becton Dickinson) and the threshold for selection of CD34+ cells was based on the level of staining obtained with an isotype-matched control IgG,-PE antibody (Dako MS, Glostrup, Denmark). Purity of the separated CD34' cells was assessed by analysis of an aliquot of sorted cells and was routinely greater than 98%.
Adhesion Assays
Source of P-selectin. Adhesion assays with BMMNC or CD34+ cells were performed using either Chinese hamster ovary (CHO) cells transfected with a human P-selectin cDNA or using purified human platelet-derived P-selectin. The former was generated by electroporating CH0 cells (Gene-Pulser; Bio-Rad, Richmond, CA) with a linearized full-length P-selectin cDNA cloned into the eukaryotic expresion vector pCDM8 (generously supplied by Dr Brian Seed, Massachusetts General Hospital, Boston, MA) together with a 10-fold molar excess of the plasmid pSV2Neo encoding resistance to the neomycin analogue (3418. C H 0 cell clones expressing Pselectin were isolated after 2 weeks of selection in growth medium (Ham's F12 and 10% FCS) supplemented with G418 (GIBCO/BRL) at 300 mg/mL, expanded, and maintained in the same medium for subsequent studies. One clone exhibiting high level P-selectin expression as demonstrated by flow cytometric analysis using a monospecific polyclonal rabbit antiserum (see below) was used for all experiments presented here. P-selectin purified from human platelets was prepared as previously described3' and stored at -70°C in 0.02 mom Tris buffer, pH 7.4, 0.15 m o m NaCI, 0.1% Triton X-100, and 0.001 moVL CaCIz (storage buffer).
Adhesion assays with CHO-P-selectin cells. To investigate the ability of CD34+ cells to bind to P-selectin, CD34+ cells isolated by FACS as described above were washed in assay medium (RPMI-1640 and 2.5% FCS) and incubated at 106/mL in the presence of 200 mCi "Cr (sodium chromate; Dupont-NEN, Wilmington, DE) for 30 minutes at 37°C and then washed three. times in the same medium. Peripheral blood neutrophils prepared by Ficoll separation of dextran-sedimented peripheral blood were labeled with "Cr under identical conditions. For the adhesion assays, CHO-P-selectin cells and untransfected CH0 cells were plated in 96-well plates (Nunc MS, Kamstrup, Denmark) at 3 X IO4 cells/well 24 hours before the assay. 51Cr-labeled cells were added in duplicate at 10' (CD34+ cells) or triplicate at 4 X l@/well (neutrophils) and incubated for 30 minutes at 37"C, washed twice to remove unbound cells, and then lysed by the addition of 1 % Triton X-100. Radioactivity associated with the lysates was quantitated by liquid scintillation counting. To show specificity of adhesion, assays were performed after the incubation of CHO-P-selectin cells with Fab fragments (10 mg/ mL) generated from an affinity-purified preparation of rabbit antihuman P-selectin antibody, as described." As a control, cells were incubated with an identical concentration of preimmune Fab fragments.
Adhesion assays with purified P-selectin. CD34' cells and BMMNC were assayed for their ability to bind purified plateletderived P-selectin immobilized on plastic. For experiments involving CD34' cells, 96-or 24-well plates (Nunc) were coated with purified P-selectin diluted in storage buffer to a final concentration of 20 mdmL for 4 hours at room temperature. Wells coated in parallel with the storage buffer alone served as a control. Unbound P-selectin was then removed and the wells were washed copiously with assay buffer before commencing the assay. CD34+ cells were labeled with "Cr as described above and diluted in assay medium to a final concentration of 5 X lo4 cells/well and incubated for 30 minutes at 37°C. Wells were then washed twice and assayed for bound radioactivity after the addition of Triton X-100, as described above. Alternatively, the assays were performed in 24-well plates by adding unlabeled CD34' cells (2 X 10' cells/mL) at 5 X l@/mL per well. Upon completion of the assays, 2% glutaraldehyde (Sigma, St Louis, MO) in HBSS containing 2 mmoVL Ca2+ was added to fix cells and adhesion was quantitated by counting the mean number of cells bound in five randomly selected 1OOX fields in each of the three replicate wells. Specificity of adhesion to P-selectin was shown by the addition of anti-P-selectin Fab fragments as described above.
To assess the role of divalent cations, assays were performed in the presence of 5 mmoVL EGTA or EDTA. Temperature dependence of adhesion to P-selectin was investigated by performing assays at 4°C and 37°C. The susceptibility of adhesion to shear stress was assessed by performing the assays on an orbital shaker at 60 rpm. Assays involving the myeloid cell line HL60 were performed under identical conditions.
To investigate the adhesion of BMMNC to P-selectin, BMMNC were subjected to a single round of plastic adherence to remove monocytes for 2 hours at 37°C. The plastic nonadherent population was washed twice in assay medium and resuspended to 1 X 106/mL and transferred to 90-mm bacteriologic grade petri dishes coated with P-selectin as described above. After 30 minutes at 37"C, nonadherent cells were carefully removed, the plates were washed thrice to remove residual nonbound cells, and the cells were pooled with the first fraction (P-selectin nonadherent). BMMNC remaining attached to the petri dish (P-selectin adherent fraction) were removed by gentle pipetting in Ca2+h4gZ+-free HBSS supplemented with 0.02% EDTA at 37°C. Both the P-selectin adherent and nonadherent fractions were then washed twice in HHF at 4°C before immunophenotypic analysis or assay of hematopoietic progenitor cells, as described below. An identical procedure was used in assays performed
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Treatment of CD34' cells with proteases and neuraminidase. To investigate the nature of the ligand for P-selectin on CD34' cells, cell sorter-purified CD34' cells were washed in serum-free RPM1 and then incubated at 106/mL for 1 hour at 37°C in the same medium containing the following proteases: bromelain, chymopapain, chymotrypsin, dispase, elastase, papain, pronase, proteinase K, thermolysin, and trypsin at a final concentration of 20 mg/mL, with the exception of elastase (20 mg/mL), dispase (4 mg/mL), and proteinase K (1 mg/mL). All enzymes were obtained from Boehringer Mannheim (Mannheim, Germany), with the exception of papain (Sigma), chymopapain (Boots, Poole, UK), and elastase (Calbiochem). After protease treatment, cells were washed twice in assay medium and assayed for their ability to bind to purified P-selectin immobilized on plastic as described above. To determine the role of sialic acid in the binding of CD34' cells to P-selectin, sorted CD34' cells or plastic nonadherent BMMNC were incubated at 106/mL for 1 hour at 37°C in phosphate-buffered saline (PBS)/O. 1 % bovine serum albumin (BSA) alone or containing 0.1 U/mL neuraminidase (Arthrobacter ureafaciens; Calbiochem). Digestion was stopped by washing three times in assay medium. HL60 cells were treated in an identical manner. After enzyme treatment, the cells were either subjected to immunophenotypic analysis as described below or assayed for binding to P-selectin as described above.
Monoclonal Antibodies (MoAbs) and Immunophenotypic Analysis
The phenotype of BMMNC showing specific adhesion to P-selectin together with those BMMNC that failed to bind was assessed by immunofluorescence staining and flow cytometric analysis of each population. Before immunostaining, cells were washed twice in HHF and then incubated on ice for 30 minutes with HHF-NHS to block Fc receptors. The following MoAb conjugates were used: Leu4-PE (CD3). LeuM3-PE (CD14), LeuM1-FITC (CD15). Leul2-PE (CD19), HPCA-2-PE (CD34; all from Becton Dickinson); 3A1-PE (CD7). J5-PE (CD10; Coulter Corp, Hialeah, FL); CD20-PE, glycophorin A-fluorescein isothiocyanate (FITC) and isotype-matched FITC-or phycoerythrin (PE)-conjugated nonbinding control antibodies (all from Dako). Staining was performed according to the manufacturer's recommendations for 45 minutes at 4"C, after which cells were washed twice in cold HHF and fixed in PBS/l% parafomaldehyde. Flow cytometric analysis was performed using a Profile I1 flow cytometer (Coulter). Twenty thousand events were collected per sample as list mode data and analyzed using Coulter ELITE software. The cell surface phenotype of CD34' cells recovered in the P-selectin adherent and nonadherent fractions was assessed in a similar manner. The cells were stained according to manufacturer's recommendations with antibody HPCA2-FITC in combination with either LeuM9-PE (CD33), Leul7-PE (CD38), HLA-DR-PE (all from Becton Dickinson), a mixture of J5-PE and Leul2-PE, or appropriate combinations of isotype-matched FITC-or PE-conjugated nonbinding control antibodies (Dako). A total of 50,000 events were collected as list mode data for each sample, which was subsequently analyzed as above.
Multiple-color immunophenotypic analysis was also performed to examine the expression by CD34' cells of carbohydrate antigens that have been shown in previous studies to function on P-selectin ligands. BMMNC were stained with HPCA-2-PE in combination with either of two CDlSILe"-specific antibodies LeuMl (Becton Dickinson) or lGlO (a kind gift from Dr R. Andrews, Fred Hutchinson Cancer Center, Seattle, WA), antibody CSLEX-l (in the form of tissue culture supernatant) that recognizes sialyl Lex,40 or an IgM control antibody, 1A2. After 45 minutes of incubation at 4°C. cells were washed twice with HHF and incubated with a 150 dilution of goat anti-IgM-FITC (p-chain specific; Southern Biotechnology Associates, Birmingham, AL) for a further 45 minutes. The cells were then washed, fixed, and analyzed as previously described. To examine the expression of sialyl Le" antigen on CD34' cells, BMMNC were incubated simultaneously with the IgM isotype anti-CD34 antibody 12.84' (Dr R. Andrews) and either of two IgG isotype anti-sialyl Le"-specific antibodies NKH-1 or FH7 (generously provided by Dr Ani1 Singhal, Biomembrane Institute, Seattle, WA) or IgG negative control antibody. After washing, specifically bound antibody was shown by incubation with 150 dilutions of a combination of goat antimouse IgM-PE and antimouse IgG-FITC (p-and y-chain specific, respectively; both from Southern Biotechnology Associates).
Two-color staining with HPCA-2-PE and antibody HECA-45242 (rat IgM) was performed essentially as described above except that sheep antirat-FITC (Silenus, Victoria, Australia) was used at a 150 dilution to detect HECA-452 antibody. Three-color staining with CD34 antibody HPCA-l (MylO; Becton Dickinson) and HECA-452 in combination with LeuM9-PE, Leul7-PE. Leul2-PE, or HLA-DR-PE was performed in the following sequence. After incubation sequentially with HPCA-l, antimouse IgG-biotin (Southern Biotechnology Associates) and streptavidin-ECD (Coulter) excess sites on the antimouse IgG were blocked by 30 minutes of incubation with a combination of control IgG1, IgG2a, and lgG2b ascites at I: 100. This was followed by incubation with HECA-452 together with PEconjugated antibody or PE-conjugated IgG-control, washing, and a final incubation with sheep antirat-FITC. A total of lo4 events were collected as list mode data. Immunofluorescence staining with each of the carbohydrate antigen-specific antibodies listed above was also performed before and after neuraminidase treatment of BMMNC.
Three-color staining of BMMNC with CD34 antibody HPCA-2-PE (Becton Dickinson), HECA-452, and CSLEX-1 was performed as follows. After 45 minutes of incubation with HPCA-2-PE and HECA-452 at 4"C, the cells were washed twice with HHF and incubated with a 150 dilution of sheep antirat-FITC. Cells were then resuspended in 10% normal rat serum and incubated for 45 minutes at 4°C to block free sites on the sheep antirat-FITC reagent. The addition of CSLEX-1 or 1A2 control antibody was followed sequentially by monoclonal rat antimouse IgM biotin and streptavidin-APC (1:50 dilution; Becton Dickinson). A total of lo4 CD34+ events were collected as list mode data.
Hematopoietic Progenitor Cell Assays
Clonogenic assays. Granulocyte-macrophage colony-forming cells (CFU-GM), erythroid progenitors (BFU-E), and multipotent colony-forming cells (CFU-Mix) were assayed as previously de~cribed.4~ Briefly, triplicate l-mL cultures were established in 35-mm dishes in Iscove's Modified Dulbecco's Medium (IMDM) supplemented with 0.9% methylcellulose, 30% FCS, 1% BSA, 3 mmoll L L-glutamine, and 5 X 2-mercaptoethanol. Colony growth was stimulated by the addition of 10 ng of each of recombinant human interleukin-3 (1L-3), IL-6, granulocyte-macrophage colony-stimulating factor (GM-CSF; generously provided by Steve Clark, Genetics Institute, Boston, MA), IL-lp, granulocyte-CSF (G-CSF), stem cell factor (SCF; Amgen, Thousand Oaks, CA), and 4 U of erythropoietin (Eprex; Janssen Cilag, Aukland, New Zealand). CFU-GM, BFU-E, and CFU-Mix were enumerated on day 14 according to standard criteria. All cultures were established in triplicate by plating IO3 CD34' cells per plate and 2 to 5 X lo4 BMMNC per plate.
Long-term BM culture (LTBMC). The P-selectin adherent and nonadherent BMMNC fractions were assayed for their ability to initiate and maintain hematopoiesis in LTBMC as previously deLTBMCs were initiated in triplicate on confluent, irradiated (20 Gy "CO) cultures of allogeneic BM stromal cells with either For personal use only. on October 23, 2017. by guest www.bloodjournal.org From lo7 unfractionated BMMNC or with the proportion of this number that were recovered as P-selectin adherent or nonadherent, respectively, after adhesion to dishes coated with purified P-selectin as described above. Culture medium comprised a-medium adjusted to 360 mOsM with NaCl and supplemented with myoinositol, folic acid, 3 mmoVL L-glutamine, mom ,B-mercaptoethanol, mom hydrocortisone sodium succinate, 12.5% horse serum (GIBCOISRL), and 12.5% FCS. Cultures were maintained by weekly demidepopulation as described'" and CFU-GM recovered in the nonadherent population at each week were assayed as described above. Clonogenic progenitor cells present in the adherent layer at week 5 of culture were also assayed after enzymatic detachment of the cells using Trypsin-EDTA (GIBCOBRL).
Pre-progenitor cell (Pre-CFU) assay. This is a stroma-free, cytokine-dependent suspension culture assay previously reported by this lab~ratory,~'.~~ based on that described by Iscove et al,46 which measures the de novo generation of Cm-GM as an index of precursors (pre-CFU) of Cm-GM. Assays were established in triplicate l-mL cultures in 24-well plates with I d CD34' cells isolated by FACS from P-selectin adherent and nonadherent BMMNC fractions and from BMMNC plated in wells coated in storage buffer only. Each I-mL culture comprised IMDM, 30% FCS, 1% BSA, 3 mmoV L L-glutamine, 5 X mom P-mercaptoethanol and was supplemented with the following recombinant growth factors at 10 ng/ mL: IL-lp, IL-3, IL-6, G-CSF, GM-CSF, and SCF (as previously de~cribed).'~ Additional factors were added to the same final concentration on day 7 and on days 14 and 21 and the cultures were split 1:lO into fresh medium containing growth factors. CFU-GM present after 14, 21, and 28 days of culture were enumerated as described above.
First-strand cDNA synthesis and polymerase chain reaction (PCR). Total cellular RNA was prepared from cell lines HL60 and KGla and from FACS double-sorted BM-derived CD34' cells with RNAzoI (Biotecx Lab Inc, Houston, TX), as per the manufacturer's recommendations. cDNA was prepared in a standard 40-mL reaction4' using 1 mg of total RNA template, oligo-dT as primer, and Superscript Moloney murine leukemia virus (MMLV) Reverse transriptase (400 U; Life Technologies, Grand Island, NY). Expression of PSGL-14' was assessed by PCR amplification using a standard protocol.49 Two milliliters of the resultant first-strand cDNA mixture was diluted in a 50-mL PCR reaction [ 1 X buffer = 67 mmoVL Tris HCI, pH 8.8, 16.6 mmom (NH4),S0,, 0.45% Triton X100, 200 mg/mL gelatin, 2 mmoVL MgCI2, and 200 mmoVL each dNTP] containing 100 ng of each primer. This mixture was heated to 96°C for 5 minutess and snap-chilled, and 2.5 U of Amplitaq DNA Polymerase (Perkin Elmer Cetus, Branchburg, NJ) was added. Reaction mixes were overlayed with mineral oil and amplification was achieved by incubation in a Perkin-ElmerKetus thermal cycler. Typical cycling conditions were 94°C for 2 minutes, 60°C for 2 minutes, and 72°C for 2 minutes for 40 cycles, with a final 10 minutes of incubation at 72°C. Oligonucleotides PSGL-I/FP (5"GCCCTC-GAGGAAGCTITCCCATGCTCTGCTG-3') and PSGL-l/RP (5'-AGCGGATCCGAGGTGGGGTCTTGCCAAAACAG-3'), which span the 5' (nucleotides, and the 3' (nucleotides, 1282-1304) untranslated region, respectively, amplify a 1,297-bp fragment. To control for the integrity of the various RNA preparations, the expression of CD3450 was also assessed using oligonucleotides oh5 (5'-CTCCAGAGAGACAACClTGAAG-3') and oli6 (5"GGAGT'IT-GCTGGAAAT'ITCTG), which span exon 3 (654-673) and exon 6 (1040-1051), respectively (generously provided by Dr B Davis, Geraldine Brush Cancer Research Institute, San Francisco, CA), which amplify a 386-bp fragment under the conditions described above. After amplification, 10 mL of each reaction mixture was analyzed by 1.5% agarose gel electrophoresis and visualized by ethidium bromide staining.
Statistics. Data points derived from multiple experiments are reported, except where stated, as the mean 2 l standard error of the mean (SEM). Significance levels were determined by two-sided nonpaired Student's t-test analysis.
RESULTS
CD34' Cells From the BM Adhere to P-Selectin
A mean of 88% (range, 82% to 100%; n = 5) of marrow CD34' showed adhesion to CHO-P-selectin transfectants (Fig 1B) that was specifically inhibited by affinity-purified polyclonal rabbit antihuman P-selectin Fab fragments ( Fig   1A) . A similar proportion of CD34' cells also adhered to bacteriologic dishes coated with purified human platelet-derived P-selectin. Adhesion required the presence of divalent cations, was independent of temperature (ie, occurred equally well at 4°C and 37"C), and occurred under both static and nonstatic conditions ( Fig 1C) . As with assays performed with C H 0 cell transfectants, adhesion was completely abrogated by anti-P-selectin antibody (data not shown).
To determine whether adhesion to P-selectin was a specific property of more immature hematopoietic cells, we examined the binding of plastic-adherence depleted, but otherwise unfractionated BMMNC to dishes coated with purified P-selectin. A mean of 25.2% of BM cells specifically adhered to P-selectin, approximately 60% of which were granulocytic cells (Table 1 ) comprising all maturation stages from myeloblasts to segmented neutrophils. A small but reproducible proportion of T cells bound to P-selectin, but the majority were recovered in the nonadherent fraction together with the majority of B cells and erythroid cells. Significantly, CD34' cells were 2.5-fold enriched in the P-selectin adherent fraction of the BM and nearly fivefold depleted in the nonbinding population, confirming data obtained using purified CD34' cells. Of the P-selectin adherent CD34+ cells, a significant proportion coexpressed CD33j' and CD38,j2 antigens previously shown to be present on mature myeloid and erythroid progenitor cells (Fig 2) . Notably, CD34' cells coexpressing the B-cell-restricted antigens CD10 and CD19 were recovered only in the P-selectin nonbinding population (Fig 2) .
Commited Progenitors and Their Precursors Adhere to P-
Selectin
In accord with the above two-color phenotypic analyses, virtually all detectable myeloid (CFU-GM) and multipotential colony-forming cells (Cm-Mix), together with approximately 80% of erythroid progenitors (BFU-E), were recovered in the population of cells that bound to P-selectin regardless of whether plastic nonadherent BM mononuclear cells (Table 2) or CD34' cells (Table 3) were used as the starting population. All three classes of progenitors were correspondingly absent or depleted from the respective Pselectin nonadherent cell fractions and their adhesion to Pselectin was specifically blocked by anti-P-selectin antibody, partially in the case of marrow mononuclear cells and almost completely in the case of assays performed with purified CD34+ cells (Tables 2 and 3) .
Primitive hematopoietic progenitors (pre-CFU) with the capacity to initiate and sustain hematopoiesis in vitro repre- BMMNC obtained by density separation and subjected to a single round of plastic adherence to remove monocytes. The plastic nonadherent population was transferred to bacteriologic grade petri dishes coated with P-selectin. After 30 minutes at 37°C. nonadherent cells were carefully removed, the plates were washed three times to remove residual unbound cells, and the cells were pooled with the first fraction (P-selectin nonadherent). P-selectin adherent cells were removed by the addition of HBSS supplemented with 0.02% EDTA. Both fractions were washed twice in FACS buffer before immunofluorescence staining and flow cytometric analysis, which was performed using the following antibody conjugates: Leu4-PE (CD31, LeuM3-PE (CD14). LeuM1-FITC (CD151, 3A1-PE (CD71, J5-PE (CD101, CD19-PE, CD2O-PE, anti-glycophorin A-FITC, and isotype-matched, non-binding FITC-and PE-conjugated control antibodies. Cells were analyzed using a Profile II flow cytometer. Twenty thousand events were collected per sample as list mode data and analyzed using Coulter ELITE software. Data represent the mean -t SE of three experiments. 24 -well plates were coated with purified P-selectin at a final concentration of 20 mg/mL. Purified CD34' cells were added and incubated, as described above, at 4°C or at 4°C on an orbital shaker at 60 rpm to simulate shear stress. To assess the role of divalent cations, assays were performed in the presence of 5 mmol/L EDTA or EGTA. Upon completion of the assays, the cells were fixed and adhesion was quantitated by counting the mean number of cells bound in five randomly selected lOOx fields per well. All assays were set up in triplicate. The data in (C) represent the mean 2 SE of three experiments. sent a minor proportion of the CD34' population and are characterized, in part, by their lack of expression of CD38.52 CD34TD38 cells were enriched by a mean of 3.5-fold in the P-selectin adherent fraction (range, 2.8-to 6.4-fold; n = S ; Fig 2) , suggesting the likelihood that pre-CFU would exhibit the property of adhesion to P-selectin. Accordingly, BM mononuclear cells separated by adherence into P-selectin binding and nonbinding populations were assayed for their capacity to initiate hematopoiesis in a standard stromal cell-dependent LTBMC procedure. As shown in Fig 3A, production of CFU-GM over S weeks in culture was only detected in cultures initiated with unfractionated BMMNC or P-selectin adherent BMMNC. The P-selectin nonadherent population showed essentially no potential for generation of clonogenic cells.
An identical trend was observed when CD34' cells present in unfractionated, P-selectin adherent and P-selectin nonadherent BMMNC were assayed for their ability to generate nascent CFU-GM in a recently described stroma-free, cytokine-dependent suspension culture a~say"~".~' (Fig 3B) .
The Nature of the Ligand for P-Sselectin on CD34' Cells
Treatment of CD34' cells with a variety of proteases, including Trypsin, thermolysin, papain, bromelain, and elastase, markedly decreased their binding to P-selectin ( Fig  4A) . showing that the receptor for P-selectin on CD34' cells appears to be located on a glycoprotein and not a glycolipid associated with the cell surface. Neuraminidase treatment of CD34' cells completely abrogated their binding to P-selectin (Fig 4B) , implying a prominent role for sialic acid in the For personal use only. on October 23, 2017. by guest www.bloodjournal.org From Fig 2. The cell surface phenotype of CD34' cells that bind to P-selectin. BMMNC adherent and nonadherent t o P-selectin (detailed in Table 1 ) were stained using antibody HPCA-2-FITC (CD341 in combination with either LeuM9-PE (CD331, Leul7-PE lCD381, HLA-DR-PE, a mixture of J5-PE (CD101 and CD19-PE, or appropriate combinations of isotype-matched FITCor PE-conjugated nonbinding control antibodies. Cells were washed, fixed, and analyzed as described ( Table 1) . Each two-parameter histogram was generated from 20,000 events stored as list mode data.
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strucure and function of the ligand. These data are in accord with the observation that P-selectin is able to bind to the tetrasaccharide sialyl Lewis" (SLe')'"'' and a stereoisomer, sialyl Lewis" (SLe"). To assess the expression of these carbohydrate antigens on CD34' cells, MoAbs CSLEX-I"" and HECA-452" were used. MoAb CSLEX-I, specific for the a2-3 sialosylated form of the fucosylated lactosamine, lacto-N-fucopentaose 111 (SLe')), is expressed on granulocytes,
CD34-FITC
monocytes. and both normal (nonmyeloid) and tumor cells.J" Indirect immunofluorescence and flow cytometry showed that MoAb CSLEX-I bound at high levels to a subpopulation (33.58 2 1.0%. n = S) of CD34-cells (Fig SA) . MoAb HECA-452, which identifies the cutaneous lymphocyte-associated antigen. CLA." reported to function as a ligand for E-selectin on skin-associated memory T cells." recognizes neuraminidase-sensitive structures involving a domain com- Committed hematopoietic progenitor cells adhere to P-selectin. Hematopoietic progenitor cells in the P-selectin adherent and nonadherent fractions of BMMNC obtained as described in Table 1 were assayed by plating in triplicate (2.5 x 10' cells in clonogenic assays). CFU-GM. BFU-E, and CFU-Mix were scored on day 14 according to standard criteria. Where indicated, affinity-purified rabbit antihuman P-selectin Fab fragments and preimmune rabbit lg Fab fragments were incubated on the P-selectin coated plates at 10 pg/mL for 1 hour before the addition of cells. Data represent the mean -c SD; n = 2. Numbers in parentheses represent actual clonogenic cell numbers.
Ficoll-separated BMMNC subjected to one round of plastic adherence (2 hours at 37°C).
For personal use only. on October 23, 2017. by guest www.bloodjournal.org From mon to both sialyl Le" and sialyl Lea.57 HECA-452 was found to bind to approximately 35% of CD34' cells (Fig 5B) .
Given the similarity in the carbohydrate epitopes identified by CSLEX-l and HECA-452, these data suggested the possibility that similar glycoprotein antigens were being identified by the two MoAbs on CD34' cells. This was confirmed by subsequent flow cytometric studies (data not shown). No cross-blocking between CSLEX-1 and HECA-452 was observed in these experiments, suggesting that the two antibodies bind to distinct antigenic determinants. Consistent with this observation, three-color analysis with anti-CD34 antibody, CSLEX-1, and HECA-452 shows colinear staining of approximately 30% of the CD34+ population (data not shown). Binding of both MoAbs was abolished by neuraminidase treatment of CD34' cells (data not shown). Collectively, these data imply that CSLEX-1 and HECA-452 recognize antigenically distinct epitopes presented on the same glycoprotein structure. Significantly, HECA-452 inhibited the adhesion of CD34' and HL60 cells to purified P-selectin by 53% and 72%, respectively, showing that, in addition to its role as a receptor for E-selectin, the HECA-452 antigen also functions as a ligand for P-selectin on hematopoietic progenitor cells.
FACS of the CD34+CSLEX-l+, CD34'HECA-452+ and CD34+CSLEX-l-, CD34'HECA-452-subpopulations demonstrated clonogenic progenitors in all fractions. Relative to the CD34+ population, BFU-E numbers were consistently diminished in the subpopulations identified by HECA-452 and CSLEX-1 and either unchanged or slightly increased in the corresponding negative subpopulations (Fig 5C) . Pre-CFU activity assayed under stroma-free, cytokine-dependent conditions was consistently enhanced in the CD34'HECA-452+ and CD34TSLEX-1' subpopulations and markedly diminished in the respective negative subpopulations ( Fig  5D) . Three-color flow cytometric analyses showed expression of CSLEX-1 antigen by 78% of CD34'CD38-cells (data not shown). Notably, in all BM samples analyzed, the majority (95%) of CD34+CD19+ B-lymphoid cells lacked detectable expression of CSLEX-1 antigen (data not shown), a phenotype correlating well with their lack of binding to Pselectin, as shown above.
The recent molecular cloning of a P-selectin ligand ZANNETTINO ET AL (PSGLfrom the promyelocytic cell line HL60 prompted us to investigate whether total CD34' cells or sorted subpopulations expressed this gene. Because the small numbers of cells available precluded the use of a more quantitative technique, reverse transcription (RT)-PCR amplification was used. Oligonucleotide primers were designed in accordance with the published sequence to generate a 1,297-bp product by RT-PCR amplification. Significantly, a band of expected size was produced from total CD34' cells (Fig 6A, lane  5) . Subsequent automated sequence analysis showed 100% sequence homology of this product with the published PSGL-1 sequence (data not shown). In addition, a PCR product of expected size was observed in both CD34'CSLEXl + (Fig 6B, lane 1) and CD34'CSLEX-1- (Fig 6B, lane 3 ) sorted subpopulations.
DISCUSSION
Current evidence supports the hypothesis that the restriction of primitive hematopoietic progenitors to the BM involves developmentally regulated adhesive interactions between progenitor cells and various components of the stromal microenvi~onment.~.~"~ A number of reports have documented interactions mediated by integrins, Ig superfamily members, and CD44." In addition, a role for cell-cell adhesion mediated by the specific lectin-like protein-carbohydrate interactions has been shown in murine hematopoietic tissues. 59 The selectin family of adhesion molecules function as calcium-dependent lectins,'"22 but there are few reports that have investigated the potential involvement of selectins in the interaction of human hematopoietic progenitors within the BM microenvironment.
This study demonstrates that hematopoietic progenitor cells, including lineage-restricted clonogenic progenitors and more primitive precursors with the ability to initiate hematopoiesis in vitro, exhibit the property of adhesion to P-selectin. Binding of CD34+ hematopoietic progenitors was shown to be cation dependent but independent of temperature and shear stress, in accord with characteristics previously described for the adhesion of mature leukocytes to Pessentially all myeloid (CFU-GM) progenitors bound to Pselectin. Erythroid development was accompanied by a loss selectin.21.22,30-33 The majority of erythroid (BFU-E) and . CD%+/P-selectin adherent (W), and CD34+/P-selectin nonadherent (W) populations using a stroma-free, cytokine-dependent assay. CD34* cells were isolated by FACS as described (Fig 1) from unseparated BMMNC and from the P-selectin adherent and nonedhrent BMMNC fractions. Assays were set up in triplicate using lo' CD34+ cells per group in medium supplemented with 10 nglmL each of purified recombinant human IL-lp, IL-3, IL-6, G-CSF, GM-CSF, and SCF. Additional factors were added at the same concentrations on daya 7 and 14. On deys 7.14. and 21, the cells were harvested, washed, and assayed for CFU-GM as previously described. The data show CFU-GM production/lO' CD%* cells for each group and represent the mean ? SE of three experiments. 3473 in ability to bind P-selectin, as shown by the recovery of the majority of maturing glycophorin A+ cells in the P-selectin nonbinding fraction of BMMNC. B cells similarly failed to adhere to P-selectin but, unlike the erythroid lineage, presumptive B-cell progenitors identified by their coexpression of CD34 and CD19 antigensa also demonstrated lack of adhesion even at this earliest phenotypically defined stage of B-cell development.
In addition to clonogenic hematopoietic progenitors, Pselectin was also shown to bind more primitive hematopoietic precursors (pre-CFU), as shown by their capacity for the de novo generation of clonogenic cells in both standard stroma-containing LTBMC and stroma-free, cytokine-dependent suspension culture assays. Thus, adhesion to P-selectin is maintained throughout myeloid development from the most primitive to the most mature lineages but is progressively lost as cells develop along the erythroid and Blymphoid pathways. Collectively, these data show that committed myeloid progenitors and their precursors, a population closely related hierarchically to hematopoietic stem cells with long-term repopulating potential in vivo, can be separated from the majority of BMMNC by virtue of their adherence to P-selectin.
The precise nature of the ligand(s) for P-selectin on CD34+ cells remains to be determined. Incubation of CD34+ cells with a variety of proteases markedly decreased their binding to P-selectin, demonstrating that the P-selectin ligand on CD34+ cells appears to be located on a glycoprotein and not on a glycolipid associated with the cell surface. In addition, treatment of CD34' cells with neuraminidase completely abrogated their binding to P-selectin, indicating that sialic acid is essential in the structure and function of the ligand. These data are in accord with previously published observations concerning the characteristics of the P-selectin ligand on the human promyelocytic leukemia cell line HL606'362 and suggest the possibility that a similar, if not identical sialosylated glycoprotein may comprise a P-selectin ligand on both cell types. MoAbs CSLEX-lN and HECA-45242 recognize neuraminidase-sensitive carbohydrate antigens, sialyl Lex, and a epitope common to both sialyl Le" and sialyl Le", respectively. Sialyl Le" and sialyl Le" have been shown previously to function as ligands for both Eselectin and P-selectin on other leukocyte^.^^^^^ Both MoAbs showed significant binding to a subpopulation of CD34+ cells from normal marrow and, although consistent with the recent finding of Karakantza et a1,64 this is contrary to the published findings of Muroi et al. 6s366 Their report showed that normal marrow-derived CD34+ cells did not express detectable levels of SLe"; however, this may be attributed to their use of an MoAb with differing epitope specificity to CSLEX-1. Additionally, three-color flow cytometric analysis also showed a precise codistribution of CSLEX-1 and HECA-452 antigens on CD34+ cells, implying recognition of the same glycoprotein antigen by the two MoAbs. Importantly, the majority of the commited myeloid progenitors (CFU-GM) and more primitive precursors (pre-CFU) were present in the CSLEX-1' and HECA-452' sorted subpopulations, consistent with their phenotype of binding to P-selectin. To our knowledge, this represents the first report to (A) Effect of protease digestion on the adhesion of CD34+ cells t o P-selectin. CD34+ cells were incubated at 106/mL for 1 hour at 37°C in RPM1 containing proteases at a final concentration of 20 mglmL, with the exception of elastase (20 mglmL), dispase (4 mg/mL), and proteinase K (1 mg/mL). After protease treatment, cells were washed and assayed for their ability to bind to P-selectin as described in Fig IC. (B) Neuraminidase inhibits the adhesion of CD34+ cells t o P-selectin. Sorted CD34+ cells were incubated at 106/mL for 1 hour at 37°C in PBSl 0.1% BSA alone or containing 0.1 UlmL neuraminidase (Arthrobacter ureafaciens). HL60 cells were treated in an identical manner. Digestion was stopped by washing three times in assay medium, and cells were assayed for adhesion t o purified P-selectin as described above. Data represent the mean 2 SE; n = 2. demonstrate the expression of these carbohydrate structures by primitive human hematopoietic progenitors. In contrast, the number of erythroid progenitors (BFU-E), were consistently diminished in the HECA-452+ and CSLEX-I+ subpopulations, somewhat discordant with the observation that the majority BFU-E were recovered in the P-selectin adherent fraction of BMMNC or CD34' cells. This would suggest that, unlike myeloid progenitors, BFU-E uses alternate Pselectin ligand(s) not recognized by CSLEX-I and HECA-452 MoAbs. Additionally, as demonstrated herein, approximately 88% of all CD34+ cells bind via P-selectin, yet the antigen(s) recognized by these two MoAbs are expressed on only 35% of these cells. This finding suggests, therefore, that the CSLEX-l and HECA-452 antigens cannot account for all the binding observed. Considering these data, our observations suggest that the P-selectin ligand on the remainder of these cells may comprise a form of sialyl LeX that is additionally sialylated or otherwise modified in such a way as to prevent recognition by sialyl L e x specific antibodies, CSLEX-l and HECA-452. An analogous observation was made by Berg et aI5' with regard to the cutaneous lymphocyte-associated antigen (CLA), which represents a ligand for E-selectin on skin-associated memory T cells. of CSLEX-l immunoreactivity showed expression of PSGL-1 in both subpopulations. We are currently preparing antibodies to PSGL-l to allow for a more definitive assessment of the contribution made by this glycoprotein in the adhesion of hematopoietic progenitors to P-selectin. Nevertheless, based on these RT-PCR studies, it is tempting to speculate that SLex-containing carbohydrate structures decorating PSGL-l may account for the P-selectin binding phenotype displayed by CD34TSLEX-I + cells. However, expression of PSGL-l by the CD34'CSLEX-1-subpopulation suggests that this protein may also play a role in the adhesion of these cells to P-selectin, presumably through sialic acid containing carbohydrate structures not recognized by CSLEX-l or HECA-452, as described above. Alternatively, there may exist additional protein structures that, when appropriately glycosylated, can serve as Pselectin ligands. This hypothesis is supported by the recent work of Lenter et al,h7 who demonstrated the existence of up to three ligands for P-selectin on HL60 cells. One ligand showed specificity for P-selectin, whereas the other two exhibited binding to both P-and E-selectin. The possible existence of such alternative P-selectin ligands on hematopoietic progenitors must remain the subject of future studies. In summary, the binding of primitive hematopoietic progenitors to P-selectin has several important implications. First, by mediating the initial fast and shear-resistant adhesion and subsequent "rolling" along endothelial cells entering the marrow, P-selectin could provide an important prerequisite for transmigration mediated by other adhesive mechanisms such as integrin-mediated interactions.33.36 In accordance with this, a previous report has shown expression of P-selectin by a proportion of BM endothelial cells.h*Second, the existence of a soluble form of P-selectin"* with possible antiadhesive function might provide a mechanism for release of cells, including immature progenitors, from the marrow under both steady-state physiologic conditions and during enforced mobilization as occurs after administration of cytokines or high-dose ~hemotherapy.~"'~ Finally, the binding of primitive progenitors to P-selectin may provide a useful tool for the selective isolation and manipulation of cells suitable for BM transplantion. 
